Skip to main content
915 TLDR
Health
1 read

New Research Highlights Broader Benefits of GLP-1 Medications Beyond Weight Loss

KVIA••CNN Newsource
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

Recent studies reveal that GLP-1 medications, such as Wegovy and Zepbound, may offer significant health benefits beyond weight loss. While 10-15% of users are classified as 'non-responders' in terms of weight loss, these drugs have shown potential in improving heart health and liver conditions, particularly metabolic dysfunction-associated steatohepatitis (MASH). The FDA recently approved Wegovy for treating MASH, which affects about 6% of U.S. adults. Experts suggest that insurance coverage criteria should evolve to include these additional benefits, as current policies focus primarily on weight loss metrics. This shift could enhance treatment accessibility for those who do not lose weight but still gain health improvements.

Key Details: • Wegovy was FDA-approved for MASH in August 2023. • 10-15% of GLP-1 users may not experience significant weight loss. • Insurance companies currently require at least 5% weight loss for continued coverage. • Research indicates GLP-1s can reduce inflammation and improve heart health independently of weight loss.

health weight-loss medications heart-health liver-health

People & Organizations

FDAUniversity of TorontoBeth Israel Deaconess Medical CenterDr. Daniel DruckerDr. Jody DushayDr. Maria Gonzalez-RellanDr. Harlan KrumholzProfessor John DeanfieldUniversity College London

Related Articles

KVIA•May 27

U.S. Establishes Ebola Care Facility in Kenya Amid Ongoing Outbreak

In response to a growing Ebola outbreak in the Democratic Republic of Congo, the Trump administration is setting up a specialized facility in Kenya to provide immediate care for Americans infected with the virus. This initiative aims to prevent Ebola cases from entering the U.S. by allowing quicker access to treatment without the lengthy medevac process. Critics argue that the U.S. has sufficient domestic capabilities to treat Ebola and express concerns over the ethical implications of prioritizing American patients in a foreign country. Meanwhile, U.S. travelers returning from affected regions will be screened at select airports, including the newly added JFK in New York.

Health
1 min read
KVIA•May 27

Copa del Mundo: Desafíos de Salud Pública en El Paso y Más Allá

La Copa Mundial de la FIFA, que comenzará en unas semanas, plantea serias preocupaciones sobre la salud pública, especialmente en El Paso y otras ciudades anfitrionas. Con un brote de ébola en África y un aumento de casos de sarampión en EE.UU., México y Canadá, los expertos advierten sobre los riesgos de enfermedades infecciosas durante este evento masivo. Se espera que la competencia, que contará con 48 equipos por primera vez, atraiga a millones de visitantes, lo que podría facilitar la transmisión de enfermedades. Las autoridades de salud pública están enfocadas en la preparación y respuesta a estos desafíos, incluyendo el manejo de enfermedades respiratorias y el impacto del calor en la salud de los asistentes.

Health
2 min read
KTSM•May 27

VA Initiates Study on MDMA Therapy for Veterans with PTSD

The Department of Veterans Affairs (VA) is set to conduct a trial examining the safety and effectiveness of MDMA-assisted therapy for treating post-traumatic stress disorder (PTSD) among veterans. This initiative is significant as it explores alternative treatment options for those suffering from PTSD, a condition that affects many veterans. The study aims to provide insights into the potential benefits of MDMA in therapeutic settings, which could lead to new treatment protocols. Veterans and their families should stay informed about the outcomes of this study, as it may impact future PTSD treatment options.

Health
1 min read
KTSM•May 27

VA Initiates Review of MDMA Therapy for Veterans with PTSD

The Department of Veterans Affairs is set to conduct a trial review to assess the safety and effectiveness of MDMA-assisted therapy for veterans suffering from post-traumatic stress disorder (PTSD). This initiative aims to explore alternative treatment options for veterans who may not respond to traditional therapies. The outcome of this review could significantly impact the mental health treatment landscape for veterans, potentially offering new hope for those struggling with PTSD. As the trial progresses, updates will be provided to keep the community informed about findings and implications.

Health
1 min read